Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251342 | SCV000312511 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000251342 | SCV000334227 | benign | not specified | 2015-10-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000540106 | SCV000638434 | benign | Facioscapulohumeral muscular dystrophy 2 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000251342 | SCV001476128 | benign | not specified | 2024-08-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003422175 | SCV004144728 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | SMCHD1: BP4, BS1 |
Breakthrough Genomics, |
RCV003422175 | SCV005214834 | likely benign | not provided | criteria provided, single submitter | not provided |